Nasdaq:US$14.51 (-0.21) | HKEX:HK$22.88 (-0.18) | AIM:£2.19 (+0)
搜索结果
上一篇文章   |   下一篇文章
公告及新闻稿, 其他业务 | 2014-04-17

Chi-Med and Sinopharm complete regulatory approval for the establishment of new China drug distribution and marketing Joint Venture